As part of AMD Awareness Month, and having declared the fourth week in February Access in Sight – National Macular Degeneration Advocacy and Action Week, the Age-related Macular Degeneration Foundation (AMDF) is inviting members of the AMD community to come to Washington, DC, on February 28-29, to meet with their representatives in Congress and the Senate to [Read More]
Category: Latest News
Volunteers Needed for Participation in Dry AMD Seminar
On March 1, Dr. Todd Durham (Ph.D., Senior Vice President, Clinical & Outcomes Research, Foundation Fighting Blindness) will lead a dry AMD patient-focused drug development seminar. The online event is open to all (patients, families, professionals) and will include a panel of patients talking about their experiences with dry AMD. Volunteers for the panel are [Read More]
Where Are We Now?
A Summary of the Past 30 Years of Low Vision Research and Development (An update presented to the International Low Vision Support Group by Director Dan Roberts) Macular Degeneration Support’s International Low Vision Support Group will soon celebrate its 30th year as a leading outreach to people affected by macular degeneration and other diseases leading [Read More]
First Human Eyeball Transplant Accomplished
Eye specialists at New York University Langone Health have announced success with the first transplantation of a complete human eyeball. High-voltage lineman Aaron James, 46, lost his eye in an electrocution accident on June 10, 2021. His multiple surgeries included a partial face transplant, during which the surgeons decided to also replace his eye. This [Read More]
Survey for Individuals Living with Neovascular Age-related Macular Degeneration
We hope this message finds you well. Prevent Blindness is helping VOZ Advisors, a consulting firm that specializes in patient advocacy and engagement during the drug development process. They are currently working with a global biopharmaceutical company to gain a deeper understanding of the challenges and experiences faced by individuals living with neovascular age-related macular degeneration [Read More]